Evidence map›Paper›PMID 37507639›Full record

ArticlePurinergic signalling2024

The role of pyruvate-induced enhancement of oxygen metabolism in extracellular purinergic signaling in the post-cardiac arrest rat model.

Koichiro Shinozaki, Vanessa Wong, Tomoaki Aoki, Kei Hayashida, Ryosuke Takegawa, Yusuke Endo, Harshal Nandurkar, Betty Diamond, Simon C Robson, Lance B Becker

Open access · greenAbstract read
In one paragraph

Article in Purinergic signalling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Koichiro ShinozakiThe Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA. shino@gk9.so-net.ne.jp.
Vanessa WongThe Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
Tomoaki AokiThe Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
Kei HayashidaThe Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
Ryosuke TakegawaThe Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
Yusuke EndoThe Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
Harshal NandurkarAustralian Centre for Blood Diseases, Monash University, Melbourne, Australia.
Betty DiamondThe Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
Simon C RobsonDepartment of Anesthesia: Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Lance B BeckerThe Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
Northwell Health · USFeinstein Institute for Medical Research · USHofstra University · USHarvard University · USMonash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purine nucleotide adenosine triphosphate (ATP) is a source of intracellular energy maintained by mitochondrial oxidative phosphorylation. However, when released from ischemic cells into the extracellular space, they act as death-signaling molecules (eATP). Despite there being potential benefit in using pyruvate to enhance mitochondria by inducing a highly oxidative metabolic state, its association with eATP levels is still poorly understood. Therefore, while we hypothesized that pyruvate could beneficially increase intracellular ATP with the enhancement of mitochondrial function after cardiac arrest (CA), our main focus was whether a proportion of the raised intracellular ATP would detrimentally leak out into the extracellular space. As indicated by the increased levels in systemic oxygen consumption, intravenous administrations of bolus (500 mg/kg) and continuous infusion (1000 mg/kg/h) of pyruvate successfully increased oxygen metabolism in post 10-min CA rats. Plasma ATP levels increased significantly from 67 ± 11 nM before CA to 227 ± 103 nM 2 h after the resuscitation; however, pyruvate administration did not affect post-CA ATP levels. Notably, pyruvate improved post-CA cardiac contraction and acidemia (low pH). We also found that pyruvate increased systemic CO

Indexed as

Adenosine TriphosphatePyruvic AcidSignal TransductionAnimalsDisease Models, AnimalHeart ArrestMaleOxygenOxygen ConsumptionRatsRats, Sprague-DawleyAdenosine TriphosphateOxygenPyruvic AcidAdenosine triphosphateEnergy metabolismGas exchangeMitochondriaOxygen consumptionPyruvate

Identifiers

PMID37507639
PMCPMC11303634
OpenAlexW4385377307

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.